-
-
-
-
-
-
-
Ipsen to Acquire Epizyme, Expanding Its Portfolio in Oncology
-
-
-
-
-
-
-
Epizyme Announces CEO Succession
-
-
-
-
-
-
-
Epizyme (EPZM) Announces Agreements for Up to $270 Million in Funding to Support Tazemetostat Commercialization and Pipeline Advancement
-
-
-
-
-
-
-
Sierra Oncology Appoints Dr. Andrew Allen to its Board of Directors
-
-
-
-
-
-
-
Epizyme Appoints Robert Bazemore President and Chief Executive Officer
-
-
-
-
-
-
923,812 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All